Irish Prime Minister, Mr. Bertie Ahern launches BioUETIKON
BioUETIKON,
the new biotech services division of Chemie Uetikon (CU) and Chemie +
Papier Holding (CPH), was officially launched on Monday 28th April in
Dublin, Ireland by the Taoiseach, Mr. Bertie Ahern TD.
> Read more
A Certificate of Suitability (CEP) for Ketamine Hydrochloride is available
End of October 2007, a Certificate of Suitability (CEP) with the European Pharmacopoeia for Ketamine HCl produced at Uetikon has been granted by the EDQM
> Read more
Technologisch weltweit fit
CU Chemie Uetikon hat für 13 Millionen Euro die Kapazität ihrer Wirkstoffproduktion verdoppelt.
> Read more
Erfolgreiche ISO-Zertifizierung
Nachdem zwei GMP Inspektionen durch die amerikanische Gesundheits-
behörde (FDA) in Folge ohne Beobachtungen (2002 und 2006) erfolgreich absolviert wurden, folgte
> Read more
"Auf Wachstumskurs"
(German press release)
CU Chemie Uetikon investiert in Wirkstoffproduktion
> Read more
Press Release Biouetikon
In September 2006 CU Chemie Uetikon, a division
of the Swiss based CPH Chemie and Papier Holdings AG, acquired an 80% share in the service orientated bioprocessing company Archport
Ltd.
> Read more
Further investment in our production capacity
The board of directors of the CPH holding group decided at the last meeting in Luzern to invest an additional 13.5 Mill. Euro. This investment completes the production trains 12 and 13 in the FDA approved facilities of CU Chemie Uetikon Lahr.
> Read more
Successful FDA inspection
Once again, CU Chemie Uetikon was successfully inspected by the U.S. Food and Drug Administration (FDA) without any observation (no form 483 issued).
> Read more
